{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T13:08:14Z","timestamp":1767877694556,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T00:00:00Z","timestamp":1689033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T00:00:00Z","timestamp":1689033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000056","name":"National Institute of Nursing Research","doi-asserted-by":"publisher","award":["UM1AI068633"],"award-info":[{"award-number":["UM1AI068633"]}],"id":[{"id":"10.13039\/100000056","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000056","name":"National Institute of Nursing Research","doi-asserted-by":"publisher","award":["UM1AI068615"],"award-info":[{"award-number":["UM1AI068615"]}],"id":[{"id":"10.13039\/100000056","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000056","name":"National Institute of Nursing Research","doi-asserted-by":"publisher","award":["UM1AI106707"],"award-info":[{"award-number":["UM1AI106707"]}],"id":[{"id":"10.13039\/100000056","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s10461-023-04125-w","type":"journal-article","created":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T08:02:04Z","timestamp":1689062524000},"page":"4114-4123","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Acceptability and Use of the Dapivirine Vaginal Ring and Daily Oral Pre-exposure Prophylaxis (PrEP) During Breastfeeding in South Africa, Malawi, Zimbabwe, and Uganda"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7189-8669","authenticated-orcid":false,"given":"Marie C. D.","family":"Stoner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imogen","family":"Hawley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Mathebula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizea","family":"Horne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliane","family":"Etima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doreen","family":"Kemigisha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prisca","family":"Mutero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adlight","family":"Dandadzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linly","family":"Seyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zayithwa","family":"Fabiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Scheckter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxensia","family":"Owor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer E.","family":"Balkus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth T.","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,11]]},"reference":[{"key":"4125_CR1","volume-title":"WHO Technical brief: preventing HIV during pregnancy and breastfeeding in the context of pre-exposure prophylaxis (PrEP)","author":"World Health Organization","year":"2017","unstructured":"World Health Organization. WHO Technical brief: preventing HIV during pregnancy and breastfeeding in the context of pre-exposure prophylaxis (PrEP). Geneva: World Health Organization; 2017."},{"key":"4125_CR2","unstructured":"WHO. Promoting proper feeding for infants and young children. Geneva: World Health Organization; 2019 [cited 2021 Sep 24]. Available from: http:\/\/www.who.int\/nutrition\/topics\/infantfeeding\/en\/"},{"issue":"2","key":"4125_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001608","volume":"11","author":"AL Drake","year":"2014","unstructured":"Drake AL, Wagner A, Richardson B, John-Stewart G. Incident HIV during pregnancy and postpartum and risk of mother-to-child HIV transmission: a systematic review and meta-analysis. PLoS Med. 2014;11(2): e1001608.","journal-title":"PLoS Med"},{"issue":"1","key":"4125_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/infdis\/jiy113","volume":"218","author":"KA Thomson","year":"2018","unstructured":"Thomson KA, Hughes J, Baeten JM, John-Stewart G, Celum C, Cohen CR, et al. Increased risk of HIV acquisition among women throughout pregnancy and during the postpartum period: a prospective per-coital-act analysis among women with HIV-infected partners. J Infect Dis. 2018;218(1):16\u201325.","journal-title":"J Infect Dis"},{"key":"4125_CR5","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01930-18","author":"LM Noguchi","year":"2019","unstructured":"Noguchi LM, Hoesley C, Kelly C, Scheckter R, Bunge K, Nel A, et al. Pharmacokinetics of dapivirine transfer into blood plasma, breast milk, and cervicovaginal fluid of lactating women using the dapivirine vaginal ring. Antimicrob Agents Chemother. 2019. https:\/\/doi.org\/10.1128\/AAC.01930-18.","journal-title":"Antimicrob Agents Chemother"},{"key":"4125_CR6","unstructured":"Department of Health Republic of South Africa. Guidelines for expanding combination prevention and treatment options for sex workers: oral pre-exposure prophylaxis (PrEP) and test and treat (T&T). 2016. Available from: https:\/\/www.nicd.ac.za\/assets\/files\/PrEPandTTGuidelines-FinalDraft-11May2016.pdf"},{"key":"4125_CR7","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1056\/NEJMoa1108524","volume":"367","author":"JM Baeten","year":"2012","unstructured":"Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al. Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women. N Engl J Med. 2012;367:399\u2013410. https:\/\/doi.org\/10.1056\/NEJMoa1108524.","journal-title":"N Engl J Med"},{"key":"4125_CR8","doi-asserted-by":"crossref","unstructured":"Brown ER, Hendrix CW, van der Straten A, Kiweewa FM, Mgodi NM, Palanee-Philips T, et al. Greater dapivirine release from the dapivirine vaginal ring is correlated with lower risk of HIV-1 acquisition: a secondary analysis from a randomized, placebo-controlled trial. J Int AIDS Soc. 2020; 23(11):e25634","DOI":"10.1002\/jia2.25634"},{"key":"4125_CR9","doi-asserted-by":"publisher","unstructured":"van der Straten A, Ryan JH, Reddy K, Etima J, Taulo F, Mutero P, et al. Influences on willingness to use vaginal or oral HIV PrEP during pregnancy and breastfeeding in Africa: the multisite MAMMA study. J Int AIDS Soc 2020;23:e25536. https:\/\/doi.org\/10.1002\/jia2.25536","DOI":"10.1002\/jia2.25536"},{"issue":"8","key":"4125_CR10","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1097\/QAD.0000000000001452","volume":"31","author":"ET Montgomery","year":"2017","unstructured":"Montgomery ET, Van Der Straten A, Chitukuta M, Reddy K, Woeber K, Atujuna M, et al. Acceptability and use of a dapivirine vaginal ring in a phase III trial. AIDS. 2017;31(8):1159\u201367.","journal-title":"AIDS"},{"key":"4125_CR11","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/S1473-3099(14)70847-3","volume":"14","author":"RM Grant","year":"2014","unstructured":"Grant RM, Anderson PL, McMahan V, Liu A, Amico KR, Mehrotra M, et al. Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. Lancet Infect Dis. 2014;14:820\u20139.","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"4125_CR12","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1007\/s10461-012-0317-8","volume":"17","author":"EM Van Der Elst","year":"2013","unstructured":"Van Der Elst EM, Mbogua J, Operario D, Mutua G, Kuo C, Mugo P, et al. High acceptability of HIV pre-exposure prophylaxis but challenges in adherence and use: qualitative insights from a phase I trial of intermittent and daily PrEP in at-risk populations in Kenya. AIDS Behav. 2013;17(6):2162\u201372.","journal-title":"AIDS Behav"},{"issue":"16","key":"4125_CR13","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1097\/QAD.0000000000000801","volume":"29","author":"A Van Den Straten","year":"2015","unstructured":"Van Den Straten A, Montgomery ET, Musara P, Etima J, Naidoo S, Laborde N, et al. Disclosure of pharmacokinetic drug results to understand nonadherence: results from a qualitative study. AIDS. 2015;29(16):2161\u201371.","journal-title":"AIDS"},{"issue":"4","key":"4125_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0125458","volume":"10","author":"A Corneli","year":"2015","unstructured":"Corneli A, Perry B, Agot K, Ahmed K, Malamatsho F, Van Damme L. Facilitators of adherence to the study pill in the FEM-PrEP clinical trial. PLoS ONE. 2015;10(4): e0125458.","journal-title":"PLoS ONE"},{"key":"4125_CR15","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1080\/19317611.2017.1297754","volume":"29","author":"Z Duby","year":"2017","unstructured":"Duby Z, Mensch B, Hartmann M, Montgomery E, Mahaka I, Bekker LG, et al. Achieving the optimal vaginal state: using vaginal products and study gels in Uganda, Zimbabwe, and South Africa. Int J Sex Health. 2017;29:247\u201357.","journal-title":"Int J Sex Health"},{"key":"4125_CR16","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1097\/QAD.0000000000001868","volume":"32","author":"ET Montgomery","year":"2018","unstructured":"Montgomery ET, Stadler J, Naidoo S, Katz AWK, Laborde N, Garcia M, et al. Reasons for nonadherence to the dapivirine vaginal ring: narrative explanations of objective drug-level results. AIDS. 2018;32:1517\u201325.","journal-title":"AIDS"},{"key":"4125_CR17","unstructured":"WHO. WHO recommends the dapivirine vaginal ring as a new choice for HIV prevention for women at substantial risk of HIV infection [Internet]. Geneva: World Health Organization; 2021. Available from: https:\/\/www.who.int\/news\/item\/26-01-2021-who-recommends-the-dapivirine-vaginal-ring-as-a-new-choice-for-hiv-prevention-for-women-at-substantial-risk-of-hiv-infection"},{"key":"4125_CR18","unstructured":"The Health Times. #BREAKING: dapivirine, vaginal ring approved for use in Zimbabwe - HealthTimes. 2021 [cited 2021 Oct 7]. Available from: https:\/\/healthtimes.co.zw\/2021\/07\/14\/breaking-dapivirine-vaginal-ring-approved-for-use-in-zimbabwe\/"},{"key":"4125_CR19","unstructured":"Bunge K, Makanani B, Fairlie L. MTN-042 Phase 3b, Randomized, Open Label Safety Trial of Dapivirine Vaginal Ring and Oral TRUVADA\u00ae Use in Pregnancy Microbicide Trials Network. 2021."},{"key":"4125_CR20","unstructured":"Noguchi L, Owor M, Gat B, Horne E, Mgodi N, Taulo F, et al. Phase 3B, randomized, open-label, safety study of dapivirine vaginal ring and oral emtricitabine 200mg\/tenofovir disoproxil fumarate 300 mg tablet in breastfeeding mother-infant pairs. AIDS 2022. [cited 2022 Aug 22]. Available from: https:\/\/programme.aids2022.org\/Abstract\/Abstract\/?abstractid=12893"},{"key":"4125_CR21","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1192\/bjp.150.6.782","volume":"150","author":"JL Cox","year":"1987","unstructured":"Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression: development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry. 1987;150:782\u20136.","journal-title":"Br J Psychiatry"},{"key":"4125_CR22","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1056\/NEJMcp011542","volume":"347","author":"KL Wisner","year":"2002","unstructured":"Wisner KL, Parry BL, Piontek CM. Postpartum depression. N Engl J Med. 2002;347:194\u20139.","journal-title":"N Engl J Med"},{"key":"4125_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12913-017-2031-8","volume":"17","author":"M Sekhon","year":"2017","unstructured":"Sekhon M, Cartwright M, Francis JJ. Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework. BMC Heal Serv Res. 2017;17:1\u201313. https:\/\/doi.org\/10.1186\/s12913-017-2031-8.","journal-title":"BMC Heal Serv Res"},{"key":"4125_CR24","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1007\/s10461-021-03205-z","volume":"25","author":"AJ Mayo","year":"2021","unstructured":"Mayo AJ, Browne EN, Montgomery ET, Torjesen K, Palanee-Phillips T, Jeenarain N, et al. Acceptability of the dapivirine vaginal ring for HIV-1 prevention and association with adherence in a Phase III trial. AIDS Behav. 2021;25:2430\u201340. https:\/\/doi.org\/10.1007\/s10461-021-03205-z.","journal-title":"AIDS Behav"},{"key":"4125_CR25","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/QAI.0000000000002028","volume":"81","author":"A Van Der Straten","year":"2019","unstructured":"Van Der Straten A, Browne EN, Shapley-Quinn MK, Brown ER, Reddy K, Scheckter R, et al. First impressions matter: how initial worries influence adherence to the dapivirine vaginal ring. J Acquir Immune Defic Syndr. 2019;81:304\u201310.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"11","key":"4125_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0224898","volume":"14","author":"JB Griffin","year":"2019","unstructured":"Griffin JB, Ridgeway K, Montgomery E, Torjesen K, Clark R, Peterson J, et al. Vaginal ring acceptability and related preferences among women in low- And middle-income countries: a systematic review and narrative synthesis. PLoS ONE. 2019;14(11): e0224898.","journal-title":"PLoS ONE"},{"key":"4125_CR27","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1089\/apc.2017.0075","volume":"31","author":"A Van Der Straten","year":"2017","unstructured":"Van Der Straten A, Shapley-Quinn MK, Reddy K, Cheng H, Etima J, Woeber K, et al. Favoring \u201cpeace of mind\u201d: a qualitative study of African women\u2019s HIV prevention product formulation preferences from the MTN-020\/ASPIRE trial. AIDS Patient Care STDS. 2017;31:305.","journal-title":"AIDS Patient Care STDS"},{"key":"4125_CR28","doi-asserted-by":"publisher","first-page":"e1002133","DOI":"10.1371\/journal.pmed.1002133","volume":"13","author":"LM Mofenson","year":"2016","unstructured":"Mofenson LM. Tenofovir Pre-exposure prophylaxis for pregnant and breastfeeding women at risk of hiv infection: the time is now. PLOS Med. 2016;13:e1002133. https:\/\/doi.org\/10.1371\/journal.pmed.1002133.","journal-title":"PLOS Med."},{"issue":"9","key":"4125_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002132","volume":"13","author":"KK Mugwanya","year":"2016","unstructured":"Mugwanya KK, Hendrix CW, Mugo NR, Marzinke M, Katabira ET, Ngure K, et al. Pre-exposure prophylaxis use by breastfeeding HIV-uninfected women: a prospective short-term study of antiretroviral excretion in breast milk and infant absorption. PLoS Med. 2016;13(9): e1002132.","journal-title":"PLoS Med"},{"issue":"9","key":"4125_CR30","doi-asserted-by":"publisher","first-page":"5616","DOI":"10.1128\/AAC.00645-16","volume":"60","author":"LM Noguchi","year":"2016","unstructured":"Noguchi LM, Montgomery ET, Biggio JR, Hendrix CW, Bogen DL, Hillier SL, et al. Detectable tenofovir levels in breast-feeding infants of mothers exposed to topical tenofovir. Antimicrob Agents Chemother. 2016;60(9):5616\u20139. https:\/\/doi.org\/10.1128\/AAC.00645-16.","journal-title":"Antimicrob Agents Chemother."},{"issue":"4","key":"4125_CR31","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1093\/jac\/dkv435","volume":"71","author":"L Palombi","year":"2016","unstructured":"Palombi L, Pirillo M, Marchei E, Jere H, Sagno J, Luhanga R. Concentrations of tenofovir, lamivudine and efavirenz in mothers and children enrolled under Option B-Plus approach in Malawi. J Antimicrob Chemother. 2016;71(4):1027\u201330.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"4125_CR32","doi-asserted-by":"publisher","first-page":"e01930-18","DOI":"10.1128\/AAC.01930-18","volume":"63","author":"LM Noguchi","year":"2019","unstructured":"Noguchi LM, Hoesley C, Kelly C, Scheckter R, Bunge K, Nel A, et al. Pharmacokinetics of dapivirine transfer into blood plasma, breast milk, and cervicovaginal fluid of lactating women using the dapivirine vaginal ring. Antimicrob Agents Chemother. 2019;63(3):e01930-18.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"4125_CR33","doi-asserted-by":"publisher","DOI":"10.1111\/mcn.13120","volume":"17","author":"V Flax","year":"2021","unstructured":"Flax V, Hawley I, Ryan J, Chitukuta M, Mathebula F, Nakalega F, et al. After their wives have delivered, a lot of men like going out: Perceptions of HIV transmission risk and support for HIV prevention methods during breastfeeding in sub-Saharan Africa. Matern Child Nutr. 2021;17(2): e13120.","journal-title":"Matern Child Nutr"},{"key":"4125_CR34","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1089\/jwh.2010.2012","volume":"19","author":"D Chibanda","year":"2010","unstructured":"Chibanda D, Mangezi W, Tshimanga M, Woelk G, Rusakaniko S, Stranix-Chibanda L, et al. Postnatal depression by HIV status among women in Zimbabwe. J Womens Health (Larchmt). 2010;19:2071\u20137.","journal-title":"J Womens Health (Larchmt)"},{"key":"4125_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12884-019-2193-y","volume":"19","author":"E Nyamukoho","year":"2019","unstructured":"Nyamukoho E, Mangezi W, Marimbe B, Verhey R, Chibanda D. Depression among HIV positive pregnant women in Zimbabwe: a primary health care based cross-sectional study. BMC Pregnancy Childb. 2019;19:1\u20137. https:\/\/doi.org\/10.1186\/s12884-019-2193-y.","journal-title":"BMC Pregnancy Childb"},{"key":"4125_CR36","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1742-4755-8-9","volume":"8","author":"M Hartley","year":"2011","unstructured":"Hartley M, Tomlinson M, Greco E, Comulada WS, Stewart J, le Roux I, et al. Depressed mood in pregnancy: prevalence and correlates in two Cape Town peri-urban settlements. Reprod Health. 2011;8:9. https:\/\/doi.org\/10.1186\/1742-4755-8-9.","journal-title":"Reprod Health"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-023-04125-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-023-04125-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-023-04125-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T13:11:40Z","timestamp":1698153100000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-023-04125-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,11]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["4125"],"URL":"https:\/\/doi.org\/10.1007\/s10461-023-04125-w","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,11]]},"assertion":[{"value":"1 July 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have not disclosed any competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the following Institutional Review Boards\/Ethics Committees and Drug Regulatory Authorities: Prevention Sciences Research Committee of the US National Institute of Allergy and Infectious Diseases; US Food and Drug Administration; College of Medicine Research and Ethics Committee; Johns Hopkins School of Public Health Institutional Review Board; Pharmacy, Medicines and Poisons Board of Malawi; Human Research Ethics Committee: (Medical), University of Witwatersrand, Johannesburg; South African Health Products Regulatory Authority; Joint Clinical Research Centre Institutional Review Board; Uganda National Council for Science and Technology; Johns Hopkins Medicine Office of Human Subjects Research Institutional Review Board; National Drug Authority of Uganda; Medical Research Council of Zimbabwe; Joint Research Ethics Committee for the University of Zimbabwe Faculty of Medicine and Health Sciences and Parirenyatwa Group of Hospitals; Research Council of Zimbabwe; Medicines Control Authority of Zimbabwe.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"All participants provided informed consent for the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The DVRs used in this study were developed and supplied by the International Partnership for Microbicides (IPM). Oral tenofovir disoproxil fumarate\/emtricitabine (TDF\/FTC) was donated by Gilead Sciences.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study Products"}}]}}